Thursday, September 11, 2025

Numinus Wellness To Acquire MedBright AI In Bid To Add Artificial Intelligence To Portfolio

Numinus Wellness (TSX: NUMI) is set to get into the artificial intelligence business. The firm this morning announced that it has entered into a letter of intent to acquire MedBright AI Investments (CSE: MBAI) to “AI-enable mental health clinics” within the US, while announcing a name change to Numinus Intelligence.

The merger is expected to combine AI-enabled clinical solutions from MedBright with that of data and experience from Numinus in an effort to improve the firms clinical operations and to capitalize on reimbursable healthcare options. The transaction is also expected to strengthen Numinus’ balance sheet, adding cash and securities of over $5.0 million.

A transition team meanwhile has been formed to cut costs, preserve cash and increase revenues prior to the transaction closing.

READ: Numinus Sees Integrated VC, MAPS Lead $6.0 Million Funding Round

Under the terms of the transaction, MedBright shareholders will receive 1.86 common shares of Numinus for each share held, resulting in the issuance of 204.7 million new shares. On a pro-forma basis, MedBright shareholders are expected to hold 39% of the resulting company.

“This acquisition is the culmination of our efforts over the past year to align Numinus with the revenue growth opportunities we see in the U.S. mental health care sector with the delivery of high-quality care to a large population of patients in need of drug-assisted therapy and mental health services. [..] We believe that harnessing our expertise and intellectual property to complement MedBright’s AI technology will amplify our ability to help those in need of care while driving revenue growth and, importantly, profitability,” commented Numinus’ CEO Payton Nyquvest.

The transaction remains subject to the negotiation of a definitive agreement, due diligence, regulatory approvals, and the approval of shareholders. A timeline for closing was not provided.

Numinus Wellness last traded at $0.05 on the TSX.


Information for this briefing was found via Numinus Wellness. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Avino Q2 Earnings: Steady As She Goes

MEG Energy: Cenovus Comes In With $7.9 BILLION Offer

Orla Mining Q2 Earnings: Musselwhite Changes Everything

Recommended

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Goliath Resources Hits 18.58 g/t Gold Over 5.00 Metres At Surebet

Related News

Numinus Wellness Halts Stock For Trading Day To Announce $17 Million Financing Closing

After halting trading in its equity all day, Numinus Wellness (TSXV: NUMI) this evening finally...

Tuesday, December 29, 2020, 04:49:21 PM

Numinus Wellness To Acquire Novamind In All Stock Transaction At $0.44 Per Share

Consolidation within the psychedelics space is getting underway, with the announcement this morning that Numinus...

Tuesday, April 12, 2022, 07:56:51 AM

Numinus Wellness Increases Financing To $15.0 Million

Numinus Wellness (TSXV: NUMI) has increased the size of the bought deal financing that it...

Monday, December 7, 2020, 10:46:35 AM

Numinus Wellness Announces Expansion To Research Lab

Numinus Wellness (TSXV: NUMI) has expansion on its mind. The company this morning announced that...

Tuesday, March 9, 2021, 08:18:23 AM

Numinus Wellness: Hot Damn! I’ve Never Invested In A Psychedelics Company Before!

The marijuana trade hadn’t even fully fallen apart yet when the first mushroom companies started...

Sunday, December 6, 2020, 09:00:00 AM